Howe & Rusling’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-80
Closed -$2K 1135
2022
Q3
$2K Sell
80
-171
-68% -$3.56K ﹤0.01% 931
2022
Q2
$5K Buy
251
+171
+214% +$3.04K ﹤0.01% 667
2022
Q1
$1K Hold
80
﹤0.01% 989
2021
Q4
$2K Hold
80
﹤0.01% 899
2021
Q3
$1K Hold
80
﹤0.01% 965
2021
Q2
$2K Hold
80
﹤0.01% 852
2021
Q1
$2K Sell
80
-100
-56% -$3.41K ﹤0.01% 862
2020
Q4
$5K Hold
180
﹤0.01% 641
2020
Q3
$4K Hold
180
﹤0.01% 623
2020
Q2
$3K Hold
180
﹤0.01% 647
2020
Q1
$1K Hold
180
﹤0.01% 762
2019
Q4
$2K Hold
180
﹤0.01% 712
2019
Q3
$2K Buy
180
+100
+125% +$1.85K ﹤0.01% 724
2019
Q2
$2K Sell
80
-160
-67% -$4.61K ﹤0.01% 700
2019
Q1
$8K Buy
+240
New +$8.52K ﹤0.01% 482

Other funds holding CVET

Howe & Rusling's CVET Position: Q4 2022 in Review

Howe & Rusling sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 80 shares — an estimated $2K sold.

Howe & Rusling first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $8K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Howe & Rusling reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 80 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $2K.
  • Howe & Rusling first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Howe & Rusling's Covetrus, Inc. Common Stock position peaked at $8K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.